1 / 32

Neurological Facts

Motor Neurone Disease Melanie Worthington Regional Care Development Adviser Lancashire & Cumbria Motor Neurone Disease Association Tel: 08453 751841 MND Connect: 08457 626262. Neurological Facts. 10 million people in UK have a neurological condition Account for 20% of acute hospital admissions

leora
Download Presentation

Neurological Facts

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Motor Neurone DiseaseMelanie WorthingtonRegional Care Development AdviserLancashire & CumbriaMotor Neurone Disease AssociationTel: 08453 751841MND Connect: 08457 626262

  2. Neurological Facts • 10 million people in UK have a neurological condition • Account for 20% of acute hospital admissions • Third most common reason for visit to GP • 850,000 carers • 69% of primary care budget is spent on long term conditions • (Department of Health) • MND – over 5,000 people in UK • Parkinson’s Disease – 120,000 • Multiple Sclerosis – 100,000

  3. What is Motor Neurone Disease

  4. Motor Neurone Disease • Every person develops the disease in a different way • Symptoms experienced depends on the area of nervous system affected • 90% - 95% of people have the sporadic form (out of the blue) • 5-10% Familial – 200-300 people • Adult Illness – most people are over 50 • Average survival 2-5 years from first symptoms. • From diagnosis 14 months average. • No cure but symptom management and medication that may improve quality or prolong life • Onset and progression is variable – can progress swiftly

  5. Who does it affect? • Relatively uncommon • Annual incidence of 2 in 100,000 • Prevalence 5-7 per 100,000 • More common in men but over 65 yrs becomes more even • GPs can expect to see 1 or 2 cases during their career

  6. What is Motor Neurone Disease? • Upper motor neurones (UMN) originate in the base of the cortex of the brain : Spasticity • Lower motor neurones (LMN) originate in the spinal cord: Wasting/Weakness • Act as transmitters that provide a chain of command for voluntary movement to muscles throughout the body • In MND this chain of command is broken as neurones degenerate

  7. Causes of MND

  8. Familial – 5-10% • Rare • Research found genetic faults • SOD 1, FUS, VCP and TDP-43 genes • Ubiquilin protein gene • Chromosone 9 Sporadic – 90% • Risk factors: genetic, environmental and lifestyle factors that may tip the balance: • mechanical/electrical trauma • Military service • High levels of exercise • Agricultural chemicals and heavy metals Evidence is often circumstantial and conflicting

  9. Types of Motor Neurone Disease

  10. Progressive Bulbar • Palsy (PBP) • 20% of cases (onset) • involves UMNs and • LMNs • dysarthria • dysphagia • emotional lability • progressive • weakness in upper • limbs/neck/ • shoulder girdle • Amyotrophic Lateral • Sclerosis (ALS) • 65 - 66% of cases (onset) • involves UMNs and • LMNs • muscle weakness – often • develops in hands and • feet first, spasticity, • hyperactive reflexes

  11. Progressive Muscular Atrophy (PMA) • 7.5% - 10% of cases • predominantly LMNs • affected (may start in • small muscles of hand) • muscle wasting, • weakness • fasciculation (may in time develop UMN involvement and may eventually develop some speech problems) • Primary Lateral • Sclerosis (PLS) • 2% of cases • rare • UMNs only • muscle weakness • stiffness • balance • dysarthria • does not shorten • survival

  12. Courseof Disease • Onset and progression variable • Is always progressive with no remissions • Usually affects both the upper and • lower motor neurones • 90% develop some bulbar symptoms • Death often through respiratory failure

  13. Site of Onset • Limb (usually distal) • Bulbar • Respiratory

  14. Early Symptoms • Depend on area of nervous system affected: • stumbling • foot drop • loss of dexterity • weakened grip • cramps • change of voice quality • slurred speech • early swallowing difficulties • muscle wasting • fatigue

  15. Diagnosis of Motor Neurone Disease

  16. Diagnosis • On average, it takes 14 months from first • symptoms to diagnose MND • First signs and symptoms often subtle and • non-specific, similar to other diseases • Person often not referred to a neurologist directly • No definitive diagnostic test

  17. How is MND Diagnosed? • Interpretation of clinical symptoms and signs • Investigations to exclude other causes • MRI • Lumbar puncture • Lack of definitive test problematic

  18. Effects of Motor Neurone Disease

  19. Progressive muscle weakness and wasting Loss of weight Fasciculation, cramp and spasticity Dysarthria-slurred effortful speech Saliva and Mucus Problems Dysphagia - poor swallow due to weakness and paralysis of bulbar muscles Respiratory muscle weakness emotional lability Cognitive changes Effects of MND

  20. Clues to respiratory muscle involvement in MND • Breathlessness • - on minimal exertion • - on lying flat • • Poor sleep • • Excessive daytime sleepiness • • Headaches on awakening • • Excessive nocturnalsweating

  21. Psychosocial Impact • Multiple losses: physical loss, loss of control, role, independence, self image, self esteem and confidence • Financial • Home environment • Communication difficulties • Increasing isolation and dependence on carers • Anxiety, Fear, Anger • Knowledge of own impending deterioration and death

  22. Cognitive changes • MND has been traditionally viewed at a • disease affecting the motor system with no • compromise of cognitive abilities • Recent research shows that 25% or more • show some cognitive changes in the frontal • lobe region • 3-5% will have fronto-temporal dementia • (FTD)

  23. What isn’t affected by MND • Senses: touch, taste, sight, smell and hearing • Bowel and bladder function • Sexual function and sexuality • Eye Muscles • Heart muscles

  24. Treatments and Interventions

  25. Aims of Management • Control of symptoms • Promote independence and control – usually • supported at home as much as possible • Plan appropriate interventions • Enable person with MND and family to live as • full a life as possible

  26. Treatments/interventionsin MND Multidisciplinary approach Palliative care Sensitive Management Person with MND Nutritional support PEG/RIG Rehabilitation medicine Pharmaceutical management of symptoms Respiratory care Disease modifying therapy

  27. Life Prolonging Interventions • Riluzole only drug to have beneficial effect on survival : 3-4 months • Respiratory care: Non-invasive ventilation (NIV) • To improve quality of life. • Median survival extended 205 days (Miller et all 2009).

  28. Multidisciplinary approach

  29. End of Life Decisions • Advanced Care Planning • Advanced decision to refuse treatment (ADART) • Advanced Statment of wishes and preferences • Preferred Priorities of Care (PPC) • Withdrawal of treatments • Tissue donations

  30. MND Association Support

  31. Provided to plwMND, families, carers and professionals • Standards of Care • Regional Care Development Advisers • Association Visitors and Volunteers • Equipment Loan • Financial Support • Care Information • MND Connect • Local Branch Network • Care Centre Programme • Education/Training • www.mndassociation.org

  32. Motor Neurone Disease • Melanie WorthingtonRCDA Lancashire and CumbriaTel: 08453 751841 melanie.worthington@mndassociation.org • Preston MND Care & Research Centre Royal Preston HospitalTel: 01772 522545 • MND Connect: 08457 626262 • mndconnect@mndassociation.org

More Related